Phenotypic Drug Discovery

Phenotypic screening is a strategy used in drug discovery to identify molecules with the ability to alter a cell's phenotype. Animal models and cell-based assays are both strategies used to identify these molecules. It’s the process of designing of drug that will target the small molecules such as peptides, RNAi, protein molecules, which results in the alteration of the phenotype of a cell or an organism in the desired manner.

  • Reverse pharmacology
  • Phenotypic screening
  • Pharmacognosy

    Related Conference of Phenotypic Drug Discovery

    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 19-20, 2025

    18th World Drug Delivery Summit

    Aix-en-Provence, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Phenotypic Drug Discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in